We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+29.37%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$424M
AUM Growth
-$209M
Cap. Flow
-$280M
Cap. Flow %
-66.07%
Top 10 Hldgs %
18.72%
Holding
171
New
54
Increased
16
Reduced
54
Closed
47

Top Buys

Rank Stock Value
1
TMDX icon
Transmedics
TMDX
+$6.6M
2
BLD
TopBuild
BLD
+$6.59M
3
PNFP icon
Pinnacle Financial Partners Inc
PNFP
+$6.46M
4
WBS icon
Webster Financial
WBS
+$6.17M
5
CNM icon
Core & Main
CNM
+$5.33M

Top Sells

Rank Stock Value
1
KNSL icon
Kinsale Capital Group
KNSL
+$13.9M
2
HQY icon
HealthEquity
HQY
+$13.2M
3
FTI icon
TechnipFMC
FTI
+$13.2M
4
OPCH icon
Option Care Health
OPCH
+$11.8M
5
RIG icon
Transocean
RIG
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 26.95%
2 Industrials 23.31%
3 Healthcare 18.68%
4 Consumer Discretionary 13.37%
5 Financials 6.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITCI
51
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.79M 0.89%
+52,885
New +$3.04M
NXT icon
52
Nextpower Inc
NXT
$14.9B
$3.7M 0.87%
78,900
-49,160
-38% -$1.92M
VCEL icon
53
Vericel Corp
VCEL
$2.29B
$3.63M 0.86%
101,895
-21,195
-17% -$738K
FSS icon
54
Federal Signal
FSS
$7.8B
$3.59M 0.85%
+46,810
New +$3.12M
SMAR
55
DELISTED
Smartsheet Inc.
SMAR
$3.59M 0.85%
75,040
+49,810
+197% +$2.12M
CRNX icon
56
Crinetics Pharmaceuticals
CRNX
$8.9B
$3.57M 0.84%
100,245
+50,265
+101% +$1.54M
FTAI icon
57
FTAI Aviation
FTAI
$22.7B
$3.53M 0.83%
76,180
-49,680
-39% -$1.98M
RPD icon
58
Rapid7
RPD
$694M
$3.52M 0.83%
+61,685
New +$3.22M
NEO icon
59
NeoGenomics
NEO
$2B
$3.45M 0.81%
+212,935
New +$3.48M
DUOL icon
60
Duolingo
DUOL
$5.71B
$3.38M 0.8%
14,915
-9,575
-39% -$1.86M
BRBR icon
61
BellRing Brands
BRBR
$1.41B
$3.35M 0.79%
+60,520
New +$2.92M
IONS icon
62
Ionis Pharmaceuticals
IONS
$9.06B
$3.16M 0.74%
+62,415
New +$2.99M
TNDM icon
63
Tandem Diabetes Care
TNDM
$1.29B
$3.13M 0.74%
+105,895
New +$2.2M
SPSC icon
64
SPS Commerce
SPSC
$2.59B
$3.11M 0.73%
16,020
-2,570
-14% -$448K
OSW icon
65
OneSpaWorld
OSW
$2.69B
$2.91M 0.69%
206,460
+39,050
+23% +$454K
CAVA icon
66
CAVA Group
CAVA
$7.25B
$2.83M 0.67%
+65,890
New +$2.3M
SHAK icon
67
Shake Shack
SHAK
$2.83B
$2.78M 0.66%
+37,555
New +$2.3M
APLS
68
DELISTED
Apellis Pharmaceuticals
APLS
$2.77M 0.65%
46,305
-64,695
-58% -$3.28M
ODD icon
69
ODDITY Tech
ODD
$624M
$2.75M 0.65%
+59,165
New +$2M
PRO
70
DELISTED
PROS Holdings
PRO
$2.75M 0.65%
70,880
-53,160
-43% -$1.91M
AGYS icon
71
Agilysys
AGYS
$3.03B
$2.65M 0.62%
+31,220
New +$2.53M
AZEK
72
DELISTED
The AZEK Co
AZEK
$2.55M 0.6%
66,775
-178,395
-73% -$5.56M
AMPH icon
73
Amphastar Pharmaceuticals
AMPH
$873M
$2.52M 0.59%
40,770
+15,595
+62% +$819K
FCFS icon
74
FirstCash
FCFS
$8.92B
$2.5M 0.59%
+23,110
New +$2.5M
SITM icon
75
SiTime
SITM
$20.6B
$2.45M 0.58%
+20,105
New +$2.28M
1 2
3
4 5

Similar funds

PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
STT
Singapore Technologies Telemedia Singapore $396M AUM 59.06% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
CF
Cypress Funds Los Angeles, California $398M AUM 8.77% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return

Lisanti Capital Growth's Q4 2023 Portfolio in Review

As of Q4 2023, Lisanti Capital Growth held 171 positions worth $424M, down 33% from $633M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lisanti Capital Growth withdrew a net $280M in Q4 2023, closing 47 positions and reducing 54 holdings. Its most notable exit was Kinsale Capital Group, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Lisanti Capital Growth opened a new position in Transmedics worth $8.64M.

  • Lisanti Capital Growth's largest Q4 2023 buy was Transmedics: 109,435 shares worth $8.64M.
  • Lisanti Capital Growth added most to Modine Manufacturing in Q4 2023, an estimated $3.56M increase.
  • Lisanti Capital Growth's biggest Q4 2023 reduction was Transocean, cutting an estimated $11.2M.
  • Lisanti Capital Growth fully exited Kinsale Capital Group in Q4 2023, selling an estimated $13.9M.
  • Lisanti Capital Growth's ten largest holdings make up 19% of its $424M portfolio in Q4 2023.
  • Lisanti Capital Growth opened 54 new positions and closed 47 in Q4 2023.
  • Lisanti Capital Growth's portfolio value fell 33% quarter-over-quarter to $424M.

Based on Lisanti Capital Growth's 13F filing for Q4 2023, filed 6 Feb 2024.